Adherence to statin therapy among patients with hypercholesterolemia in a tertiary health facility in south-south Nigeria
Main Article Content
Abstract
Background: Hypercholesterolemia may be a predictor of cardiovascular diseases and global prevalence of hypercholesterolemia is about 38%. Statins do not increase or decrease the risk of subsequent intracerebral hemorrhages, but do reduce the risk of ischemic stroke. Patients on statins for prevention of cardiovascular disease have an increased risk of cardiovascular events and mortality if they do not adhere to treatment.
Objective: The aim of this study was to assess the level of statin adherence among hypercholesterolemic patients in a tertiary health facility.
Methods: Three hundred and fifty-three hypercholesterolemic out-patients were recruited from a tertiary hospital through systematic random sampling. A validated self-reported questionnaire was used to obtain demographics characteristics, hypercholesterolemia profile and adherence to statin therapy. Data collected were organized and analysed using descriptive statistics and Chi square. Ethical considerations were observed.
Results: Response rate was 99.7%. Majority of the respondents were females (63.1%). Most of the patients had tertiary level of education (67.9%). A total of 168(47.7%) of the participants were private workers. Majority of the participants were urban dwellers (89.5%), 55.1% of the participants has cholesterol level greater than 200mg/dl. About 34.7% had an onset of the disease at age <40 and 68.2% of the participants had a family history of the disease. Atorvastatin was the most used statin drug (54.0%) followed by Rosuvastatin (34.1%) and lastly Simvastatin (11.9%). Hypertension is the most common comorbidity (89.5%) followed by diabetes (59.4%) and lastly myocardial infarction (6.0%). According to rate of adherence among participants, 57.1% showed moderate adherence while 42.9% showed non adherence.
Conclusion: This study has reported moderate adherence to statin, especially among patients with high educational status. Patients on rovastatin were more likely to take their medicine as prescribed than those on the other statins. Adherence apps on android devices are recommended.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World health Organization, (2015). Global Health Observatory (GHO) data: Raised cholesterol.
Paththinige CS, Sirisena ND, Dissanayake V, (2017). Genetic determinants of inherited susceptibility to hypercholesterolemia-a comprehensive literature review. Lipids Health Discovery; 16: 103.
Paula Byrne, Maryanne Demasi, Mark Jones, Susan M. Smith, Kirsty K. O'Brien, Robert DuBroff (2022). Evaluating the association between Low-Density Lipoprotein cholesterol reduction, relative and absolute effects of Statin treatment. JAMA Internal Medicine; 11:67
Nicholls SJ, Nissen SE, Fleming C, (2023). Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical
Trial. JAMA International Medicine;52:10
David Gaist, Luis Alberto García Rodríguez, Jesper Hallas, Stine Munk Hald, Sören Möller, Birgit B Høyer, Magdy Selim, Larry B. Goldstein (2023). Association of Statin Use with Risk of Stroke Recurrence After Intracerebral Hemorrhage; Neurology, 10.1212
Baigent, C., Blackwell, L. and Emberson J. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 376: 670-1681.
Sadowitz B, Maier KG, Gahtan V, (2010). Basic Science: Statin therapy-part 1: the pleiotropic effects of statins in cardiovascular disease. Vase
Endovascular Surg. 44: 241-251.
Beena, J. and Jimmy, J. (2011). Patient Medication Adherence: Measures in Daily practice. Oman Medical Journal, 26(3): 155-159.
Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S. (2005). Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant, (3): 381- 390.
Bartlett, JE., Kotrlik, JW. and Higgins, CC. (2001). Organizational Research: Determining appropriate sample size in survey research. Information Technology, Learning and Performance Journal 19(1): 43-49.
Anghel, LA., Farcas, AM. and Oprean, RN. (2019). An overview of the common methods used to measure treatment adherence. Medicine Pharmacy Reports. 92(2): 117-122.
Gorina M, Limonero JT, Alvarez M, (2018). Effectiveness of primary healthcare educational interventions undertaken by nurses to improve
chronic disease management in patients with diabetes mellitus, hypertension and hypercholesterolemia: A systematic review: International Journal of Nursing Studies. 86: 139- 150.
Meisa, A. and Shawn, S. (2016). Factors Affecting Adherence to Statins in Hypercholesterolemic Kuwaiti Patients: A Cross-Sectional Study. Medical Principles and Practices 26: 35-40.
Aubert, RE., Yao J., Xia, F. and Garavaglia, SB. (2010). Is there a relationship between early statin compliance and a reduction in healthcare
utilization? America Journal of Managed Care 16(6): 459-466.
Penaere T. Osahon, Lisa A. Mote and Veronica I. Ntaji (2020). Assessment of the impact of medPlan, a medication reminder mobile application, in glaucoma patients in Benin City, Nigeria. Tropical Journal of Pharmaceutical Research, 19(12): 2677- 2682.
Seyed Ml, Leila M, Hajieh S, Armaghan MA. (2016). A study of the prevalence of dyslipidemia among the adult population of Ahvaz, Iran. Diabetes and metabolic syndrome: Clinical Research and Reviews. 10(4):190-193.
Al-Hassan, YT. and Fabella, E. (2017). Lipid Profile analysis of patients in a Saudi University Clinic. Public Health International 2(3): 89-95
Afam-Anene, OC., Okorie, JN. and Maduforo, AN. (2017). Obesity, physical activity pattern and hypercholesterolemia among civil servants in Bida Niger State Nigeria. Journal of Dietitians Association of Nigeria 8: 13-24.
Odenigbo CU, Oguejiofor OC, (2009). Pattern of Medical Admission at the Federal Medical Centre, Asaba - a two year review. Nigerian Journal of Clinical Practice, 12: 395-397.
Adeloye, D., Abaa, DQ., Owolabi EO, Ale BM, Mpazanje RG. and Dewan MT., Omoyele, C., Ezeigwe, N., Wondimagegnehu, A., Harhay, M.O., Auta, A. and Adewole, IF. (2020). Prevalence of hypercholesterolemia in Nigeria: a systematic review and meta-analysis. Public Health 178: 167-178.
Akunne, OO., Godman, B., Adedapo, AD., Truter, I. and Fadare, J. (2016). Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future. Journal of Comparative Effectiveness Research 5(3):281-288.
Zhao, B. Xiaoning He, Jing Wu, Shu Y, (2020). Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China. BMC Cardiovascular Disorder, 20: 282.
Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A. (2009) Socioeconomic status and cardiovascular disease: risks and implications for
care. Nat Rev Cardiol; 6:712-22.
Khera R, Valero-Elizondo J, Das SR (2019). Cost- related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 140: 2067-75.
Colantonio LD, Huang L, Monda KL (2017). Adherence to high-intensity statins following a myocardial infarction hospitalization among
medicare beneficiaries. JAMA Cardiology; 2: 890-5.
Shang P, Liu GG, Zheng X, Ho PM, HU S, Li J (2019). Association between medication adherence and 1year major cardiovascular adverse events after acute myocardial inferction in China. J AM Heart Association 8(9):e011793